ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PROTEÍNA ÁCIDA FIBRILAR GLIAL (GFAP).
Mexico·Clase I·III. Agentes de
diagnóstico·ABBOTT LABORATORIES
DE MÉXICO, S.A. DE C.V.·Registered May 08, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ALINITY I GFAP
- Trade Name (English)
- ALINITY I GFAP
- Analysis ID
- 1340R2024 SSA
- Registration Date
- May 08, 2024
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PROTEÍNA ÁCIDA FIBRILAR GLIAL (GFAP). (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PROTEÍNA ÁCIDA FIBRILAR GLIAL (GFAP).) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1340R2024 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on May 08, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.